Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are
View All Resources

Site experience and outcomes in the Trevo Acute Ischemic Stroke (TRACK) Multicenter Registry.

September 1, 2019

Abstract, via the American Heart Association Journal:

A strong correlation between procedural volumes and clinical outcomes has been established for many highly specialized and time-dependent medical treatments including percutaneous coronary interventions (PCIs) and high-risk surgical procedures.

A previous analysis has suggested that outcomes after endovascular intervention for large vessel occlusion strokes (LVOS) are highly influenced by center volumes. However, this analysis predates the large-scale use of stent retrievers that have been demonstrated to have a steep learning curve and, therefore, may be less dependent on individual operator/center experience.
We studied the relationship between site volumes and outcomes in the Trevo Acute Ischemic Stroke (TRACK) multicenter registry with the aim to evaluate whether endovascular treatment at high-volume stroke centers, as compared with low-volume stroke centers, is associated with improvement in clinical outcomes and other performance metrics.

Publication Link:
https://www.ahajournals.org/

Related readings.

Our utmost commitment: creating what works based specifically and urgently on what’s needed. Explore additional resources, publications, and webinars to learn more.

July 22, 2024

Q’Apel Medical Announces Leadership Transition

October 12, 2021

Q’Apel Medical, Inc. Awarded U.S. Patent for its Highly Innovative SelectFlex™ Technology

August 23, 2021

Q’Apel Medical Launches Armadillo – A New Radial Artery Access Platform to Meet the Needs of Physicians and Patients

August 9, 2021

Q’Apel Medical Welcomes Thomas Berryman, Chief Financial Officer